Related Experiment Video

Updated: May 30, 2026

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure
09:38

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure

Published on: August 11, 2017

EGF receptor inhibition radiosensitizes NSCLC cells by inducing senescence in cells sustaining DNA double-strand

Meng Wang1, Fabian Morsbach, David Sander

  • 1Laboratory of Cellular & Molecular Radiation Oncology, Massachusetts General Hospital Cancer Center, Charlestown, Massachusetts, USA.

Cancer Research
|August 20, 2011
PubMed

Insights

Epidermal growth factor receptor (EGFR) inhibition with erlotinib or cetuximab induces cellular senescence, enhancing radiosensitization in non-small cell lung cancer (NSCLC) cells. This senescence, linked to DNA damage, offers a new therapeutic strategy for NSCLC treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Radiation Oncology

Background:

  • Mechanisms of epidermal growth factor receptor (EGFR) inhibition sensitizing non-small cell lung cancer (NSCLC) to ionizing radiation are unclear.
  • EGFR inhibitors like erlotinib and cetuximab are used in cancer therapy.
  • Understanding radiosensitization pathways is crucial for improving NSCLC treatment outcomes.

Purpose of the Study:

  • To investigate the radiosensitizing effects of EGFR inhibitors (erlotinib, cetuximab) in NSCLC cells.
  • To characterize the cellular response (senescence vs. apoptosis) to combined EGFR inhibition and radiation.
  • To identify potential biomarkers for predicting response to EGFR inhibitor-mediated radiosensitization.

Main Methods:

  • In vitro and in vivo studies using NSCLC cell lines and xenografts.
  • Assessment of cellular senescence and apoptosis.
  • Analysis of p53 and p16 protein expression.
  • Evaluation of radiation-induced DNA double-strand breaks.
  • Investigation of the MEK-ERK signaling pathway.

Main Results:

  • EGFR inhibition induced significant cellular senescence, not apoptosis, in irradiated NSCLC cells.
  • Senescence was dependent on wild-type p53 and reduced clonogenic survival.
  • Senescence and radiosensitization were observed in 45% of NSCLC cell lines, irrespective of p53/p16 status.
  • EGFR inhibition increased residual DNA double-strand breaks, partly mediated by MEK-ERK pathway disruption.

Conclusions:

  • Cellular senescence is a key mechanism of radiosensitization by EGFR inhibitors in NSCLC.
  • EGFR inhibition enhances radiation efficacy by increasing DNA damage and inducing senescence.
  • Assays detecting proliferative delay from senescence can help identify biomarkers for EGFR inhibitor radiosensitization.

More Related Videos

Simultaneous Imaging and Flow-Cytometry-based Detection of Multiple Fluorescent Senescence Markers in Therapy-Induced Senescent Cancer Cells08:56

Simultaneous Imaging and Flow-Cytometry-based Detection of Multiple Fluorescent Senescence Markers in Therapy-Induced Senescent Cancer Cells

Published on: July 12, 2022

SA-β-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs07:39

SA-β-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs

Published on: June 28, 2019

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...